Neurocognitive effects of neurofeedback in adolescents with ADHD: A randomized controlled trial

Journal of Clinical Psychiatry

Volumn 75, Issue 5, 2014, Pages 535-542

  Bink, Marleen ^a   Van Nieuwenhuizen, Chijs ^a,c   Popma, Arne ^d   Bongers, Lija L ^c   Van Boxtel, Geert J M ^b  

^a TILBURG UNIVERSITY   (Netherlands)

^b TILBURG UNIVERSITY   (Netherlands)

^c GGzE Foundation for Mental Health Care Eindhoven en de Kempen   (Netherlands)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PSYCHOSTIMULANT AGENT;

ACCURACY; ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; ATTENTION; ATTENTION DEFICIT DISORDER; AUTISM; CHILD; CLINICAL PRACTICE; COGNITION; COGNITIVE THERAPY; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; ECOLOGICAL VALIDITY; EFFECT SIZE; EXECUTIVE FUNCTION; HUMAN; MALE; MOTOR SPEED; MULTICENTER STUDY; NERVOUS SYSTEM PARAMETERS; NEUROFEEDBACK; OUTCOME ASSESSMENT; PATIENT COUNSELING; POST HOC ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REACTION TIME; RECALL; RESOURCE ALLOCATION; SCHOOL CHILD; SENSORIMOTOR RHYTHM NEUROFEEDBACK; SYMPTOM; TASK PERFORMANCE; WORKING MEMORY; YOUNG ADULT;

ADOLESCENT; ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BEHAVIOR THERAPY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; COMBINED MODALITY THERAPY; DEXTROAMPHETAMINE; ELECTROENCEPHALOGRAPHY; FAMILY THERAPY; HUMANS; MALE; METHYLPHENIDATE; NEUROFEEDBACK; NEUROPSYCHOLOGICAL TESTS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84901710840     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.13m08590     Document Type: Article

References (54)

1. Polanczyk G, de Lima MS, Horta BL, et al. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry. 2007;164(6):942-948. (Pubitemid 46972911)
2. Willcutt EG. The prevalence of DSM-TV attention-deficit/hyperactivity disorder: a meta-analytic review. Neurotherapeutics. 2012;9(3):490-499.
3. Holtmann M, Bolte S, Poustka F. Attention deficit hyperactivity disorder symptoms in pervasive developmental disorders: association with autistic behavior domains and coexisting psychopathology. Psychopathology. 2007;40(3):172-177. (Pubitemid 46457598)
4. Lee DO, Ousley OY. Attention-deficit hyperactivity disorder symptoms in a clinic sample of children and adolescents with pervasive developmental disorders. J Child Adolesc Psychopharmacol. 2006;16(6):737-746. (Pubitemid 46175429)
5. Simonoff E, Pickles A, Charman T, et al. Psychiatric disorders in children with autism spectrum disorders: prevalence, comorbidity, and associated factors in a population-derived sample. J Am Acad Child Adolesc Psychiatry. 2008;47(8):921-929.
6. Gjevik E, Eldevik S, Fjaeran-Granum T, et al. Kiddie-SADS reveals high rates of DSM-IV disorders in children and adolescents with autism spectrum disorders. J Autism Dev Disord. 2011;41(6):761-769.
7. Greenhill LL, Swanson JM, Vitiello B, et al. Impairment and deportment responses to different methylphenidate doses in children with ADHD: the MTA titration trial. J Am Acad Child Adolesc Psychiatry. 2001;40(2):180-187. (Pubitemid 32111021)
8. Faraone SV, Buitelaar J. Comparing the efficacy of stimulants for ADHD in children and adolescents using meta-analysis. Eur Child Adolesc Psychiatry. 2010;19(4):353-364.
9. Research Units on Pediatric Psychopharmacology Autism Network. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity. Arch Gen Psychiatry. 2005;62(11):1266-1274.
10. Cortese S, Castelnau P, Morcillo C, et al. Psychostimulants for ADHD-like symptoms in individuals with autism spectrum disorders. Expert Rev Neurother. 2012;12(4):461-473.
11. Coghill DR, Seth S, Pedroso S, et al. Effects of methylphenidate on cognitive functions in children and adolescents with attention deflcit/hyperactivity disorder: evidence from a systematic review and a meta-analysis [published online ahead of print October 12,2013]. Biol Psychiatry.
12. van Lieshout M, Luman M, Buitelaar J, et al. Does neurocognitive functioning predict future or persistence of ADHD? a systematic review. Clin Psychol Rev. 2013;33(4):539-560.
13. Hutton P, Morrison AP, Yung AR, et al. Effects of drop-out on efficacy estimates in five Cochrane reviews of popular antipsychotics for schizophrenia. Acia Psychiatr Scand. 2012;126(1):1-11.
14. Lofthouse N, Arnold LE, Hersch S, et al. A review of neurofeedback treatment for pediatric ADHD. J Arfen Disord. 2012;16(5):351-372.
15. Moriyama TS, Polanczyk G, Caye A, et al. Evidence-based information on the clinical use of neurofeedback for ADHD. Neurotherapeutics. 2012;9(3):588-598.
16. Holtmann M, Steiner S, Hohmann S, et al. Neurofeedback in autism spectrum disorders. Dev Med Child Neurol. 2011;53(11):986-993.
17. Snyder SM, Hall Jr. A meta-analysis of quantitative EEG power associated with attention-deficit hyperactivity disorder. J Clin Neurophysiol. 2006;23(5):440-455.
18. Loo SK, Makeig S. Clinical utility of EEG in attention-deficit/ hyperactivity disorder: a research update. Neurotherapeutics. 2012;9(3):569-587.
19. Gevensleben H, Holl B, Albrecht B, et al. Distinct EEG effects related to neurofeedback training in children with ADHD: a randomized controlled trial. Int J Psychophysiol. 2009;74(2):149-157.
20. Duric NS, Assmus J, Gundersen D, et al. Neurofeedback for the treatment of children and adolescents with ADHD: a randomized and controlled clinical trial using parental reports. BMC Psychiatry. 2012;12(1):107.
21. Meisel V, Servera M, Garcia-Banda G, et al. Neurofeedback and standard pharmacological intervention in ADHD: a randomized controlled trial with six-month follow-up. Biol Psychol. 2013;94(1):12-21.
22. Bakhshayesh AR, Hansen S, Wyschkon A, et al. Neurofeedback in ADHD: a single-blind randomized controlled trial. Eur Child Adolesc Psychiatry. 2011;20(9):481-491.
23. Arnold LE, Lofthouse N, Hersch S, et al. EEG neurofeedback for ADHD: double-blind sham-controlled randomized pilot feasibility trial. J Atten Disord. 2013;17(5):410-419.
24. Logemann HN, Lansbergen MM, Van Os TW, et al. The effectiveness of EEG-feedback on attention, impulsivity and EEG: a sham feedback controlled study. Neurosa Lett. 2010;479(1):49-53.
25. Vollebregt MA van Dongen-Boomsma M, Buitelaar JK, et al. Does EEG-neurofeedback improve neurocognitive functioning in children with attention-deficit/hyperactivity disorder? a systematic review and a double-blind placebo-controlled study [published online ahead of print October 30, 2013]. J Child Psychol Psychiatry.
26. van Dongen-Boomsma M, Vollebregt MA, Slaats-Willemse D, et al. A randomized placebo-controlled trial of electroencephalographic (EEG) neurofeedback in children with attention-deficit/hyperactivity disorder. J Clin Psychiatry. 2013;74(8):821-827.
27. Sonuga-Barke EJ, Brandéis D, Cortese S, et al European ADHD Guidelines Group. Nonpharmacological interventions for ADHD: systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments. Am J Psychiatry. 2013;170(3):275-289.
28. Wechsler D. Wechsler Intelligence Scale for Children. 3rd ed. San Antonio, TX: The Psychological Corporation; 1991.
29. Wechsler D. Wechsler Adult Intelligence Scale. 3rd ed. San Antonio, TX: The Psychological Corporation; 1997.
30. Kooij JJS. ADHD in Adults. Introduction to Diagnosis and Treatment, 1st ed [in Dutch]. Lisse, the Netherlands: Swets & Zeitlinger; 2002.
31. Sheehan DV, Lecrubier Y, Sheehan KH, et al. The validity of the Mini International Neuropsychiatric Interview (MINI) according to the SCID-P and its reliability. Eur Psychiatry. 1997;12(5):232-241. (Pubitemid 27298916)
32. Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(suppl 20):22-33, quiz 34-57. (Pubitemid 29001829)
33. Dallal GE. Randomization plan generator; first generator. http://www.randomization.com. Updated August 3,2007. Accessed January 20,2014.
34. Faul F, Erdfelder E, Lang AG, et al. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007;39(2):175-191.
35. Schulz KF, Altaian DG, Moher D; CONSORT Group. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMC Med. 2010;8(1):18.
36. Vink M, Van Wamel A. Dutch Basic Program ADHD for Children and Adolescents [in Dutch], Utrecht, the Netherlands: Trimbos- instituut, Netherlands Institute of Mental Health and Addiction; 2007.
37. Lubar JF. Neurofeedback for the management of attention deficit disorders. In: Schwartz MS, Andrasik F, eds. Biofeedback A Practitioner's Guide. 3rd ed. New York, NY: The Guilford Press; 2003:409-437.
38. Palsson O, Pope A, Ball JD, et al. Neurofeedback videogame ADHD technology: results of the first concept study. Annual Meeting of Association for Applied Psychophysiology and Biofeedback. Raleigh-Durham, NC; March 29-April 1,2001.
39. Brain inquiry: PET EEG 2.0 duo channel bipolar system. http://www.bramquiry.com/NeurofeedbackHardware.html. Accessed January 20,2014.
40. EEGer Neurofeedback Software. 4.2.1.Sed [computer program]. EEGer Spectrum Systems. 2005.
41. Kooij JJS, Buitelaar JK van den Oord EJ, et al. Internal and external validity of attention-deficit hyperactivity disorder in a population-based sample of adults. Psychol Med. 2005;35(6):817-827. (Pubitemid 40873382)
42. Achenbach TM. Integrative Guide for the 1991 CBCL/4-18, YSR and TRF Profiles. Burlington, VT: University of Vermont Department of Psychiatry; 1991.
43. Brickenkamp R. D2 Test of Attention [in Dutch]. Amsterdam, the Netherlands: Hogrefe, the Netherlands; 2007.
44. Lezak MD. Orientation and Attention; Attention, Concentration and Tracking. Neuropsychological Assessment. New York, NY: Oxford University Press; 2004:349-374.
45. Stroop Jr. Studies of interference in serial verbal reactions. J Exp Psychol. 1935;18(6):643-662.
46. Hammes JGW. The STROOP Color-Word Test. Manual [in Dutch]. 2nd ed. Lisse, the Netherlands: Swets and Zeitlinger; 1978.
47. Culbertson WC, Zilmer EA. Tower of London-Drexel University (TOL DX TM). 2 ed. North Tonawanda, NY: Multi-Health Systems; 2005.
48. Corp IBM. released 2012. IBM SPSS Statistics for Windows, Version 21.0. Armonk, NY: IBM Corp.
49. Gevensleben H, Holl B, Albrecht B, et al. Is neurofeedback an efficacious treatment for ADHD? a randomised controlled clinical trial. J Child Psychol Psychiatry. 2009;50(7):780-789.
50. Swanson J, Baler RD, Volkow ND. Understanding the effects of stimulant medications on cognition in individuals with attention-deficit hyperactivity disorder: a decade of progress. Neuropsychopharmacology. 2011;36(1):207-226.
51. Gur RC, Richard J, Calkins ME, et al. Age group and sex differences in performance on a computerized neurocognitive battery in children age 8-21. Neuropsychology. 2012;26(2):251-265.
52. Calamia M, Markon K, Tranel D. Scoring higher the second time around: meta-analyses of practice effects in neuropsychological assessment. Clin Neuropsychol. 2012;26(4):543-570.
53. Rapport LJ, Axelrod BN, Theisen ME, et al. Relationship of IQ to verbal learning and memory: test and retest. J Clin Exp Neuropsychol. 1997;19(5):655-666. (Pubitemid 28005007)
54. Rapport LJ, Brines DB, Theisen ME, et al. Full scale IQ as mediator of practice effects: the rich get richer. Clin Neuropsychol. 1997;11(4):375-380. (Pubitemid 28015254)